BALYASNY ASSET MANAGEMENT L.P. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,876,104
+147.9%
5,906,836
+283.6%
0.06%
+129.2%
Q2 2023$10,840,241
-35.1%
1,539,807
-43.7%
0.02%
-42.9%
Q1 2023$16,714,430
+1855.6%
2,735,586
+1945.2%
0.04%
+2000.0%
Q4 2022$854,688
-96.1%
133,754
-94.2%
0.00%
-97.0%
Q3 2022$21,924,000
+11.6%
2,288,532
+28.6%
0.07%
+4.7%
Q2 2022$19,644,000
-39.0%
1,779,389
-8.0%
0.06%
-36.6%
Q1 2022$32,201,000
+18.2%
1,934,024
+35.5%
0.10%
+8.6%
Q4 2021$27,239,000
-29.6%
1,426,835
-9.0%
0.09%
-42.2%
Q3 2021$38,678,000
+120.5%
1,568,460
+132.7%
0.16%
+94.0%
Q2 2021$17,540,000
+231.1%
674,124
+302.9%
0.08%
+219.2%
Q1 2021$5,297,000
+73.0%
167,312
+153.5%
0.03%
+52.9%
Q4 2020$3,062,000
-94.0%
66,000
-95.8%
0.02%
-95.5%
Q3 2020$51,449,000
+12387.6%
1,562,864
+10319.1%
0.38%
+9325.0%
Q2 2020$412,000
-97.5%
15,000
-97.3%
0.00%
-98.0%
Q1 2020$16,793,000
+4551.8%
560,979
+1375.8%
0.20%
+9850.0%
Q1 2019$361,000
-20.1%
38,011
-25.6%
0.00%
-33.3%
Q4 2018$452,000
-72.2%
51,115
-64.6%
0.00%
-57.1%
Q3 2018$1,623,000
+261.5%
144,287
+311.3%
0.01%
+250.0%
Q2 2018$449,00035,0770.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders